GUÍA TÉCNICA G-BIOF 02: - Instituto de Salud Pública de Chile

Calidad Farmacéutica. Center for Drug Evaluation and Research, USA
FDA, 1997. Guidance for Industry: Dissolution Testing of Immediate
Release Solid Oral Dosage Forms, US Center for Drug Evaluation and
Research , USA
FDA, 2000. Guidance for industry: Waiver of In Vivo Bioavailability and
Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms
based on Biopharmaceutics Classification System. US Food and Drug
Administration, Center for Drug Evaluation and Research, USA
FDA, 2003. Guidance for Industry: Bioavailability and Bioequivalence
Studies for Orally Administered Drug Products– General Considerations.
US Food and Drug Administration, Center for Drug Evaluation and
Research
Giarcovich, S.S., Genéricos, Similares y el problema de la
intercambiabilidad. Rev. SAFYBI 40 (101): 3-20, 2001
Global Harmonization Task Force (GHTF). Quality Management
Systems- Process Validation Guidance N 99-10, 2004
Graffner, C. Regulatory aspects of drugs dissolution from a European
perspective. Eur. J. Pharm Sci., 29, 288 – 293, 2006
Gupta E., Barends D., Yamashita E., Lentz K. Armes A., Shah V.,
Dressman J., Lipper R.. Review of global regulations concerning
biowaivers for immediate release solid oral dosage forms. Eur. J.Pharm.
Sci. 29: 315-324, 2006
ISP, 2003. Resolución Exenta Nº 1575 (05/09/2007): “Modifica
Denominación y Estructura Interna de los Departamentos que indica del
Av. Marathón 1000 – Ñuñoa – Casilla 48 – Santiago – Teléfono: 350 74 77 – Código Postal: 7780050 – www.ispch.cl
G-BIOF-02
57